Sonoma Pharmaceuticals, Inc. Quarterly Common Stock, Shares Authorized from Q1 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Sonoma Pharmaceuticals, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q1 2011 to Q3 2024.
  • Sonoma Pharmaceuticals, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 50M shares, a 108% increase year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 50M +26M +108% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 24M 0 0% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 24M 0 0% Mar 31, 2024 10-Q 2024-11-07
Q4 2023 24M 0 0% Dec 31, 2023 10-Q 2024-02-08
Q3 2023 24M 0 0% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 24M 0 0% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 24M 0 0% Mar 31, 2023 10-K 2024-06-17
Q4 2022 24M 0 0% Dec 31, 2022 10-Q 2023-02-14
Q3 2022 24M 0 0% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 24M 0 0% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 24M 0 0% Mar 31, 2022 10-K 2023-06-21
Q4 2021 24M 0 0% Dec 31, 2021 10-Q 2022-02-11
Q3 2021 24M 0 0% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 24M 0 0% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 24M 0 0% Mar 31, 2021 10-K 2022-07-13
Q4 2020 24M 0 0% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 24M 0 0% Sep 30, 2020 10-Q 2020-11-20
Q2 2020 24M 0 0% Jun 30, 2020 10-Q/A 2020-11-17
Q1 2020 24M 0 0% Mar 31, 2020 10-K 2021-07-14
Q4 2019 24M 0 0% Dec 31, 2019 10-Q 2020-02-14
Q3 2019 24M 0 0% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 24M +12M +100% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 24M +12M +100% Mar 31, 2019 10-K 2020-07-10
Q4 2018 24M +12M +100% Dec 31, 2018 10-Q 2019-02-14
Q3 2018 24M +12M +100% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 12M 0 0% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 12M 0 0% Mar 31, 2018 10-K 2019-07-01
Q4 2017 12M 0 0% Dec 31, 2017 10-Q 2018-02-14
Q3 2017 12M 0 0% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 12M 0 0% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 12M 0 0% Mar 31, 2017 10-K 2018-06-26
Q4 2016 12M -48M -80% Dec 31, 2016 10-Q 2017-02-17
Q3 2016 12M -18M -60% Sep 30, 2016 10-Q 2016-11-15
Q2 2016 12M -18M -60% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 12M -48M -80% Mar 31, 2016 10-K 2017-06-28
Q4 2015 60M +30M +100% Dec 31, 2015 10-Q 2016-02-16
Q3 2015 30M +15.7M +110% Sep 30, 2015 10-Q 2015-11-10
Q2 2015 30M +15.7M +110% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 60M +30M +100% Mar 31, 2015 10-K 2016-06-21
Q4 2014 30M +15.7M +110% Dec 31, 2014 10-Q 2015-02-12
Q3 2014 14.3M 0 0% Sep 30, 2014 10-Q 2014-11-13
Q2 2014 14.3M 0 0% Jun 30, 2014 10-Q 2014-08-12
Q1 2014 30M +15.7M +110% Mar 31, 2014 10-K 2015-06-16
Q4 2013 14.3M -85.7M -85.7% Dec 31, 2013 10-Q 2014-02-14
Q3 2013 14.3M -85.7M -85.7% Sep 30, 2013 10-Q 2013-11-19
Q2 2013 14.3M -85.7M -85.7% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 14.3M 0 0% Mar 31, 2013 10-K 2014-06-30
Q4 2012 100M 0 0% Dec 31, 2012 10-Q 2013-02-13
Q3 2012 100M 0 0% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 100M 0 0% Jun 30, 2012 10-Q/A 2012-08-31
Q1 2012 14.3M -85.7M -85.7% Mar 31, 2012 10-K 2013-06-25
Q4 2011 100M Dec 31, 2011 10-Q 2012-02-10
Q3 2011 100M Sep 30, 2011 10-Q 2011-11-03
Q2 2011 100M Jun 30, 2011 10-Q/A 2011-08-09
Q1 2011 100M Mar 31, 2011 10-K 2012-06-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.